Table: begin end state 1 11 cytoplasmic 12 32 transmembrane 33 54 non-cytoplasmic 55 72 transmembrane 73 83 cytoplasmic 84 101 transmembrane 102 106 non-cytoplasmic 107 130 transmembrane 131 147 cytoplasmic 148 167 transmembrane 168 173 non-cytoplasmic 174 195 transmembrane 196 256 cytoplasmic 257 279 transmembrane 280 292 non-cytoplasmic 293 313 transmembrane 314 324 cytoplasmic 325 347 transmembrane 348 352 non-cytoplasmic 353 380 transmembrane 381 391 cytoplasmic 392 418 transmembrane 419 423 non-cytoplasmic 424 443 transmembrane 444 466 cytoplasmic
Input: >WP_017751862.1 NCBI__GCF_000816635.1:WP_017751862.1 MEQTVNKDKKKFLRKISILATFGSLLFGYDSGVINGALTFIARKDQLNLTPLTEGLVTSS LLLGAAIGAVLMGHFSDKYGRKKVLKVLAAVFFFSTIGCSISPNAEIIIICRFIVGIGVG GVSVVVPTLLAEMAPTKIRGSLVSRDQFMIVTGQLLAYIFNGILGNVFENPGIWRYMIAI SSIPAVVLWFGMLVVPETPRWLASHGKIADALEILRQTREEQEAEAEIKEIQKNIEAESS LERATFKELGIPWIRRIVIIGCLIAIIQQFAGVNVLMYYGTTVLEKSGFGVKTALIANIG NGIMSVVASWIYMHLLSNRCNRRPLLIIGYCGTTVTWLAITIVSHVLSGSGTLPFVIVIL TMIFLAIDQATLGPLTWLLLSEIFPLRVRGMGYGVATFFNWIGNFAVGLTFPILIAYFGL SSTFLIFVLLGVLCIICAIMVVPETRGKSLEQMEDYFRSYKTRSES
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server